Lisinopril,
Lisinopril Maleate (1:1),
Lisinopril Sulfate (1:2),
Lysinopril,
MK-521,
Prinivil,
Zestril,
Lisinopril dihydrate,
83915-83-7,
Renacor,
Lisinopril (dihydrate),
UNII-E7199S1YWR,
CHEBI:6503,
E7199S1YWR,
MK-521,
Qbrelis,
HSDB 6852,
NCGC00017141-01,
(S)-Lisinopril,
CAS-83915-83-7,
Zestril (TN),
(S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate,
(S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate,
1-(N(sup 2)-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate,
DSSTox_CID_25600,
DSSTox_RID_80993,
DSSTox_GSID_45600,
Ranolip,
L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, dihydrate,
N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline dihydrate,
(S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate,
L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-,
L-Proline, 1-(N(sup 2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-,
MFCD01698825,
lisinopril-zestril,
lisinopril-dihydrat,
C21H31N3O5.2H2O,
Lisinopril [USAN:INN:BAN:JAN],
Prinivil (TN),
(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;dihydrate,
Lisinopril (USP),
Prestwick_613,
(S)-1-[N2-(1-Carboxy-3-phenylpropyl)-lysyl-proline dihydrate,
Lisinopril [USAN:USP:INN:BAN:JAN],
AC1NSFPC,
Lisinopril hydrate (JP17),
SCHEMBL542591,
CHEMBL419213,
DTXSID2045600,
Lisinopril, >=98% (HPLC),
HMS1568N04,
HMS2095N04,
HMS3712N04,
(2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid dihydrate,
Tox21_110798,
HY-18206A,
AKOS015950799,
Tox21_110798_1,
AC-6226,
AN-6585,
API0005525,
CCG-220301,
CS-2444,
KS-1078,
NCGC00179623-04,
H528,
SC-25401,
AB1004847,
AX8136408,
LS-118900,
ST24047491,
D00362,
915L837,
SR-01000801314,
SR-01000801314-3,
Lisinopril, United States Pharmacopeia (USP) Reference Standard,
L-Proline,1-(N2(1-carboxy-3-phenylpropyl)-L-lysyl)-dihydrate,(S),
Lisinopril dihydrate, British Pharmacopoeia (BP) Reference Standard,
Lisinopril dihydrate, European Pharmacopoeia (EP) Reference Standard,
Lisinopril, Pharmaceutical Secondary Standard; Certified Reference Material,
Lisinopril for peak identification, European Pharmacopoeia (EP) Reference Standard,
Lisinopril for system suitability A, European Pharmacopoeia (EP) Reference Standard,
(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid dihydrate,
lisinopril,
Prinivil,
Zestril,
Prinzide,
Lisinopril hydrate,
Lysinopril,
Zestoretic,
Mixture Name,
Lisinopril(Dihydrate),
C21H31N3O5,
Lisinopril [USAN:BAN:INN:JAN],
Deferasirox bis salicylamide impurity,
CID5362118,
CS-M-34867,
CS-O-05581,
C21-H31-N3-O5.2H2-O,
2589H,
B3290,
1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline,